We are live on ! Find out more
EP

Elkhorn Partners Portfolio holdings

AUM $157M
1-Year Est. Return 11.91%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+11.91%
3 Year Est. Return
+31.51%
5 Year Est. Return
+35.62%
10 Year Est. Return
+87.18%
AUM
$146M
AUM Growth
+$7.91M
Cap. Flow
-$1M
Cap. Flow %
-0.69%
Top 10 Hldgs %
96.62%
Holding
47
New
2
Increased
14
Reduced
17
Closed
5

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$294K
2
KW
Kennedy-Wilson Holdings
KW
+$94K
3
CRSP icon
CRISPR Therapeutics
CRSP
+$71.6K
4
META icon
Meta Platforms (Facebook)
META
+$35.2K
5
FPH icon
Five Point Holdings
FPH
+$15.8K

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$238K
2
OSK icon
Oshkosh
OSK
+$232K
3
WTM icon
White Mountains Insurance
WTM
+$217K
4
NWLI
National Western Life Group, Inc. Class A
NWLI
+$149K
5
BA icon
Boeing
BA
+$146K

Sector Composition

Rank Sector Weight
1 Financials 46.7%
2 Real Estate 45.5%
3 Communication Services 2.99%
4 Technology 1.43%
5 Materials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOFI icon
26
SoFi Technologies
SOFI
$21.5B
$69K 0.05%
15,000
+800
+6% +$3.97K
UAL icon
27
United Airlines
UAL
$40.2B
$69K 0.05%
1,825
-275
-13% -$11.2K
NEPH icon
28
Nephros
NEPH
$38M
$58K 0.04%
50,341
– –
CRSP icon
29
CRISPR Therapeutics
CRSP
$4.68B
$55K 0.04%
+1,350
New +$71.6K
BAC icon
30
Bank of America
BAC
$439B
$53K 0.04%
1,600
-2,000
-56% -$68.9K
META icon
31
Meta Platforms (Facebook)
META
$1.51T
$48K 0.03%
400
+300
+300% +$35.2K
MP icon
32
MP Materials
MP
$7.35B
$46K 0.03%
1,875
+475
+34% +$14.4K
CRDF icon
33
Cardiff Oncology
CRDF
$63.6M
$41K 0.03%
29,408
+4,108
+16% +$5.88K
CLF icon
34
Cleveland-Cliffs
CLF
$6.84B
$40K 0.03%
2,500
-8,000
-76% -$120K
FPH icon
35
Five Point Holdings
FPH
$395M
$40K 0.03%
17,000
+7,000
+70% +$15.8K
NWLI
36
DELISTED
National Western Life Group, Inc. Class A
NWLI
$28K 0.02%
100
-700
-88% -$149K
AMZN icon
37
Amazon
AMZN
$2.48T
$25K 0.02%
300
+40
+15% +$3.95K
KMI icon
38
Kinder Morgan
KMI
$70.3B
$22K 0.02%
1,200
– –
OSK icon
39
Oshkosh
OSK
$9.51B
$18K 0.01%
200
-2,700
-93% -$232K
BHC icon
40
Bausch Health
BHC
$1.69B
$6K ﹤0.01%
1,000
– –
GHM icon
41
Graham Corp
GHM
$1.17B
$4K ﹤0.01%
+405
New +$3.75K
BHVN icon
42
Biohaven
BHVN
$2.07B
– –
-102
Closed -$15K
CREX icon
43
Creative Realities
CREX
$41.4M
$0 ﹤0.01%
26
– –
DIS icon
44
Walt Disney
DIS
$172B
– –
-280
Closed -$26K
JEF icon
45
Jefferies Financial Group
JEF
$13.2B
– –
-136
Closed -$4K
MAX icon
46
MediaAlpha
MAX
$746M
– –
-2,111
Closed -$18K
VTRS icon
47
Viatris
VTRS
$20.8B
– –
-8,500
Closed -$72K
1
2

Similar funds

AC
AlpenGlobal Capital Tahoe City, California $157M AUM
SF
Seros Financial Tempe, Arizona $157M AUM 16.95% 1-Year Est. Return
BRWM
Blue Rock Wealth Management Winston-Salem, North Carolina $157M AUM 18.03% 1-Year Est. Return
SR
Syntax Research Boca Raton, Florida $157M AUM 16.51% 1-Year Est. Return
HEM
Henson-Edgewater Management Avon, Ohio $157M AUM
CF
CDC Financial Chicago, Illinois $157M AUM
IWM
IMG Wealth Management Jacksonville, Florida $157M AUM 17.95% 1-Year Est. Return
PWA
Providence Wealth Advisors Frankfort, Illinois $157M AUM 29.27% 1-Year Est. Return

Elkhorn Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Elkhorn Partners held 47 positions worth $146M, up 5.7% from $138M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Elkhorn Partners's Q4 2022 filing shows 2 new, 14 increased, 17 reduced and 5 closed positions. Its largest new stake was CRISPR Therapeutics: 1,350 shares worth $55K. The largest sale was Berkshire Hathaway Class B, an estimated $238K.

By sector, the portfolio is most concentrated in Financials at 47% of assets, up from 44% a quarter earlier, followed by Real Estate and Communication Services.

  • Elkhorn Partners's largest Q4 2022 buy was CRISPR Therapeutics: 1,350 shares worth $55K.
  • Elkhorn Partners added most to CME Group in Q4 2022, an estimated $294K increase.
  • Elkhorn Partners's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $238K.
  • Elkhorn Partners fully exited Viatris in Q4 2022, selling an estimated $72K.
  • Elkhorn Partners's ten largest holdings make up 97% of its $146M portfolio in Q4 2022.
  • Elkhorn Partners opened 2 new positions and closed 5 in Q4 2022.
  • Elkhorn Partners's portfolio value rose 5.7% quarter-over-quarter to $146M.

Based on Elkhorn Partners's 13F filing for Q4 2022, filed 14 Feb 2023.